The Latest Cardiac and Vascular News
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 24, 2019 to November 16, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages […]
SUNNYVALE, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment of Kevin Ballinger to the company’s Board of Directors. Simultaneously, the company also announced the resignation of current board […]
STOCKHOLM, Dec. 4, 2020 /PRNewswire/ — Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28. The total number of shares […]
– OMRON reinforces its involvement with AliveCor with E-series investment and strengthens the alliance between the companies for the remote management of cardiovascular conditions KYOTO, Japan, Dec.4, 2020 / PRNewswire / – OMRON Healthcare Co., Ltd. announced on November 24 the additional investment in AliveCor by its parent company, […]
Steven Brooks, M.D., MBA, FACC – Appointed EVP of Medical and Regulatory Affairs, Chief Medical Officer Donald Very, Ph.D. – Appointed EVP, Research & Development William Hearl, Ph.D. – Named Independent Member of Board of Directors JUPITER, Fla., Dec. 4, 2020 /PRNewswire/ — Marizyme, Inc. (OTCQB: MRZM), a publicly traded global biotechnology company developing products […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business. […]
Former sales leader at Corindus Vascular Robotics and Boston Scientific joins Biomodex to head up U.S. sales of growing portfolio of 3D printed solutions for patient-specific rehearsal and physician training BOSTON, Dec. 3, 2020 /PRNewswire/ — BIOMODEX®, a pioneering digital health company that offers unique and enhanced 3D printed solutions for patient-specific rehearsal […]
Incremental Reimbursement in Outpatient Setting Will Expand Availability of the Breakthrough BAROSTIM Therapy Heart Failure Treatment MINNEAPOLIS, Dec. 03, 2020 (GLOBE NEWSWIRE) — CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that the Centers for Medicare and Medicaid Services (CMS) granted […]
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 30, 2020 it granted stock options to purchase an aggregate of 62,850 shares of common stock to six new employees whose employment commenced in November 2020 as a material inducement to […]
Seasoned Medical Device Executive Joins Breakthrough Structural Heart Company CAESAREA, Israel and AGOURA HILLS, Calif., Dec. 2, 2020 /PRNewswire/ — V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced the appointment of Bill Hughes as its Chief Financial […]
